Two poster presentations at this year’s Society for Pediatric Dermatology Meeting delve into the psychological impact of the condition and a new option for management.

Most of the patients receiving the non-surgical treatment experienced a complete clearing of tumors.

Dermatology Times is counting down to the annual Fall Clinical conference in Las Vegas, Nevada, with our top 5 headlines and highlights from this year's PA and NP summer conference.

Dermatology Times is counting down to the annual fall SDPA conference in Nashville, Tennessee, with our top 10 headlines and highlights from this year's summer conference.

Leading atopic dermatitis experts delve into integrative approaches, prescription options, and strategies to encourage patients to stick with their treatment plan.

Researchers applied EB-101, a new cell therapy, to patients with recessive dystrophic epidermolysis bullosa with positive results.

Jemima Mellerio, MD, said a correct diagnosis often requires a lot of testing, questioning, and observation.

As a parent of a child with a vascular anomaly, Kumar has experienced all the emotions of having a child who is born with a skin condition.

Pediatricians are often the first to diagnose and manage pediatric atopic dermatitis, and Larry Eichenfield, MD, led a team to develop a tool to help them.

As a radiologist with Radiology Associates of Albuquerque, Jessica Williams, MD, offered pearls on imaging for young patients.

Remembering that skin conditions are not just physical, but also have a significant emotional impact, is critical to treating the whole patient.

Dermatologists can use TikTok to educate the public on skin care and dispel incorrect information.

The nail expert from Duke University shares surgical techniques from biopsy to post-operative care.

George Hightower, MD, PhD explained 4 critical conversations to discuss among dermatology colleagues to determine best care for underserved populations and neighborhoods.

Researchers noted that infants who began propranolol therapy at higher dose had a lower incidence of adverse events.

Alan Mendelsohn, MD, presented captivating Phase 3 TMB-001 PK Data in a poster session.

Sara F. Grace, MD, discussed medications and diseases that dermatologists encounter in treating patients.

Carrie Coughlin, MD, discussed how dermatologists can gain insight into their patient’s preferences using qualitative research tools.

Peter Lio, MD also explained why he considers it a bad day when he does not learn something new about this disease.

Jemima Mellerio, MD, covered recent developments for managing epidermolysis bullosa and the challenges of studying rare diseases.